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doi:10.1016/j.gmbhs.2011.11.001Abstract The aim of the present study was to investigate the potential role of an ethanolic
extract of the entire plant of Cynodon dactylon in lowering the plasma lipid parameters in rats
fed a high cholesterol diet. Wistar albino rats were randomly divided into four groups of six and
for 45 days were administered either: 0.5 ml water (negative controls); 30 mg cholesterol
(hypercholesterolemic animals); C dactylon extract at 400 mg/kg body weight (positive
control); or the same doses of both cholesterol and the extract (test animals). The effects
of C dactylon on the lipid profile were assessed by measuring the plasma concentrations of
total cholesterol (TC), triglyceride (TG), low-density lipoprotein cholesterol (LDL-c),
high-density lipoprotein cholesterol (HDL-c), and very low-density lipoprotein cholesterol
(VLDL-c). Administration of cholesterol showed significant elevation (p < 0.001) of TC,
LDL-c, VLDL-c, and TG concentrations, and of the TC:HDL-c ratio (p< 0.05). Concurrent
administration of C dactylon extract caused a significant decrease (p< 0.001) in the concen-
trations of serum TC, LDL, HDL, VLDL TGs when compared with cholesterol fed control rats.
The TC:HDL-c ratio was also declined significantly (p < 0.001). These results suggestnt of Physiology, Center for Basic Sciences, Kasturba Medical College, Bejai, Mangalore-575004,
ail.com (N. Arunkumar).
an Genomic Medicine and Biomarker Society. Published by Elsevier Taiwan LLC. All rights reserved.
Lipid-lowering effect of Cynodon dactylon extract 99lipid-lowering effects of C dactylon, which serves as a new potential natural product for
preventing hyperlipidemia.
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For centuries, the plant kingdom has been one of the largest
areas from which novel medicines are derived. The
constituents of plants often have medicinal and research
value, such as for treating diseases1 and understanding
basic natural science. Many recent studies have focused on
plant extracts in order to find new chemicals that could be
beneficial to mankind.2 Cynodon dactylon Pers. (Family:
Graminae, Durba in Bengali, Dhub in Hindi, Bermuda grass in
English) is a creeping grass found in warm climates all over
the world between 45 south and north latitudes. C dactylon
is available throughout the year. The juice of the plant is
astringent and is applied externally to fresh cuts and
wounds. It is also useful in the treatment of catarrhal
ophthalmia, dropsy, hysteria, epilepsy, insanity, chronic
diarrhea, and dysentery.3 The plant is a folk remedy for
anasarca, calculus, cancer, carbuncles, cough, hyperten-
sion, snakebites, stones, gout, fever, skin diseases, and
rheumatic infections. It has also antioxidant properties and
central nervous system depressant activities (and is also
used as an antidiabetic and antiviral agent).4 The rhizome is
used as an anti-inflammatory, diuretic, antiemetic, puri-
fying agent, and also in the treatment of dysentery.5
Hyperlipidemia is well known to play a major role in
the development of atherosclerosis, and is widely recog-
nized as a risk factor for cardiovascular diseases (CVD)
and myocardial infarction, which is a common cause of
mortality and morbidity.6,7 Chronic elevation of blood lipids
may also lead to the development of fatty liver8 and renal
damage,9 as indicated by the increased concentrations of
liver and kidney enzymes. Accumulation of lipids impairs
endothelial dysfunction, which can initiate vasoregulation,
platelet and monocyte adhesion, vascular smooth muscle
cell growth and oxidization of low-density lipoprotein
(LDL).10 Although several factors such as life style, a diet
rich in cholesterol, age, and hypertension, have been
reported to cause heart failure,11 hypercholesterolemia
due high levels of cholesterol, particularly LDL cholesterol
(LDL-c),12 is mainly responsible for CVD. Hence, decreasing
the prevalence of hyperlipidemic conditions is considered
to be an important therapeutic approach.13 Accordingly,
efforts have been made to identify the anticholesterol
effects of various medicinal plants.14,15 Thus in the present
study an attempt was made to investigate the hypolipi-
demic properties of C dactylon.
Materials and methods
Plant material
C dactylon was collected from the campus of Kasturba
Medical College, Manipal University, Mangalore, India. Itwas identified and authenticated by a plant taxonomist.
The whole green plant was washed with water and shade
dried for 3e5 days. Five hundred grams were macerated
with ethanol (80% v/v) and kept for 48 hours at room
temperature (28e30C). The extraction was filtered and
the filtrate evaporated to dryness under reduced pres-
sure at 50C (yield 15.6% w/w, dry weight basis) and
stored at 4C until use. The obtained C dactylon ethanol
extract was stored at e20C until use.16 Extract prepa-
ration was done at the Manipal College of Pharmaceu-
tical Sciences, Manipal University, Manipal. The extract
was dissolved in distilled water to a concentration of
100 mg/ml.
Acute oral toxicity study
An acute toxicity study was carried out as prescribed by the
Organization for Economic Cooperation and Development
guidelines. Prior to experimentation, Wistar rats were
fasted overnight (water withheld for 3e4 hours) and fixed
C dactylon extract doses of 50, 200, 400, and 2000 mg/kg
body weight were administered by gavage via canula intu-
bation. The extract was tolerated as no death was found up
to the maximum dose administered. Rats were observed
individually after dosing for the first 30 minutes periodi-
cally, and daily thereafter for 14 days for any toxicity signs
such as gross changes in the skin, fur, eyes, mucous
membranes, or circulatory, respiratory, autonomic, and
central nervous systems, or changes in behavior pattern. On
the basis of earlier studies16,17 the effective dose of
400 mg/kg body weight was selected for further studies.
Phytochemical screening
Chemical tests were carried out on ethanolic extracts of C
dactylon using standard procedures to identify the
constituents as described by Sofowora,18 Trease and
Evans,19 and Harborne.20
Alkaloids: About 0.2 g of the extract was warmed with
2% H2SO4 for 2 minutes. It was filtered and a few drops of
Dragencloffs reagent added. An orange-red precipitate
indicates the presence of alkaloids.
Tannins: A small quantity of extract was mixed with
water and heated in a water bath. The mixture was filtered
and ferric chloride added to the filtrate. A dark-green
solution indicates the presence of tannins.
Glycosides: The extract was hydrolyzed with dilute
HCl and neutralized with NaOH solution. A few drops of
Fehling’s solution A and B were added. A red precipitate
indicates the presence of glycosides.
Flavonoids: About 0.2 g of extract was dissolved in NaOH
solution and HCl was added. A yellow solution that turns
colorless indicates the presence of flavonoids.








100 S.R. Kaup et al.Saponins: About 0.2 g of extract was shaken with 5 ml of
distilled water and then heated to boiling. Frothing of the
extracts shows the presence of saponins.
Experimental animals
Twenty-four albino rats of both sexes (Wistar strain)
weighing 120e130 g were obtained from the animal house of
Kasturba Medical college (Manipal University), Mangalore.
They were housed in the institutional experimental animal
laboratory. The rats were kept in cages in a roommaintained
at 26e29C with a 12-hour lightedark cycle for 4 weeks to
acclimatize, and were allowed free access to food and
water. All the rats received approximately 20 g of standard
rat pellets (Lipton, India Ltd., Bangalore, India) per day,
with or without cholesterol supplementation. All the animal
procedures were carried out in strict compliance with the
institutional animal ethical committee regulations.
Cholesterol supplementation in the rat basal diet
Cholesterol powder was purchased from HIMEDIA Labora-
tories (Mumbai, India), and supplemented to the basal diet
of rats, to induce hyper cholesteremia.15
Experimental design
The effect of C dactylon plant extract on normal and
cholesterol-fed rats were studied. All the rats received
treatment for 45 days and were randomly distributed into
four groups of six animals each. Group I served as a control
rats (administered with 0.5 ml distilled water); Group II ratsTable 2 Effect of C dactylon extract on serum lipid profile in r
Parameters Group I Gro
Total cholesterol (mg/dL) 85.83 4.92*** 156
Triglyceride (mg/dL) 116.0þ 13.4*** 212
HDL-cholesterol (mg/dL) 57.33 10.00*** 127
LDL-cholesterol (mg/dL) 51.20 9.07*** 72.
VLDL-cholesterol (mg/dL) 23.20 2.69*** 42.
TC/HDL Ratio 1.512 0.013** 1.2
Values are expressed as mean SEM.
Group I - Control rats (administered with 0.5 ml distilled water); G
administered with C dactylon at a dose of 400 mg/kg body weight;
400 mg/kg body weight, in addition to oral administration of choleste
Group I versus Group II: **p< 0.05; ***p< 0.001; Group II versus Grourecieved dietary supplementation of cholesterol (hyper-
cholesterolemic rats); rats in Group III served as a positive
control and were given C dactylon at a dose of 400 mg/kg
body weight; and Group IV rats were administered C dac-
tylon extract dose of 400 mg/kg body weight, in addition to
oral administration of cholesterol. After overnight fasting
the rats were sacrificed by administering sodium pento-
barbitone; 40 mg/kg body weight. Blood samples were
collected directly via cardiac puncture using 23G needles
and 3-ml syringes and collected into EDTA tubes (Sigma
Chemicals, Gillingham, Dorset, UK). The plasma was
immediately separated by centrifugation at 3000 rpm
(relative centrifugal force, approximately 1,500 g) for 10
minutes. They were then transferred into microcentrifuge
tubes and stored under e80C until analysis. Samples were
analyzed spectrophotometrically: TG21 was estimated by
the GPO-POD method, TC22 by the CHOD-PAP method, and
high-density lipoprotein (HDL) was analyzed using kits
(Roche Diagnostics, Mannheim, Germany).
The concentration of very low-density lipoprotein
cholesterol (VLDL-c) was estimated according to Fride-
wald’s equation:23 VLDL-C Z triglycerides/5
According to Fridewald23 low density lipoprotein
cholesterol (LDL-c) can be calculated as follows:
LDL-c Z Total cholesterol - (HDL-c) e (VLDL-c).
Statistical analysis
The experimental results were expressed as mean SEM.
Data were assessed by ANOVA followed by the Student t
test. A p-value <0.05 was considered as statistically
significant.24 All data analyses were done using SPSS for
Windows version 11.0 (SPSS Inc., Chicago, IL, USA).
Results
Analysis of the phytochemical constituents of an ethanol
extract of the entire C dactylon plant (Table 1) showed the
presence of glycosides, flavonoids, alkaloids, tannins, and
saponins. Table 2 shows the values of the serum lipid profile
in Groups IeIV. Serum total cholesterol (TC), LDL-c, VLDL-c,
and TG concentrations increased significantly (p< 0.001)
after 45 days of cholesterol feeding, and the TC:HDL-c ratio
was also increased significantly (p< 0.05). Concurrentats.
up II Group III Group IV
.50 11.10xxx 83.2 2.23NS 92.2 6.46
.66 8.94xxx 122.0 11.7NS 95.8 2.23
.33 9.42xxx 52.3 12.3NS 72.2 7.08
2 12.62xxx 55.2 13.8NS 40.2 2.99
5 1.79xxx 24.4 2.34NS 19.2 0.44
18 0.018xxx 1.535 0.024NS 0.635 0.20
roup II e Hypercholesterolemia induced rats; Group III e Rats
Group IV e Rats administered with C dactylon extract dose of
rol.
p IV: xxxp< 0.001; Group I versus Group III: NS Z not significant.
Lipid-lowering effect of Cynodon dactylon extract 101administration of C dactylon extract caused a significant
decrease (p< 0.001) in the concentrations of serum TC,
LDL-c, HDL-c, VLDL-c, and TG, and in the TC:HDL-c ratio
when compared with cholesterol-fed control rats.
Discussion
In developing countries, the incidence of CVD is increasing
at an alarming rate, and India is on the verge of a cardio-
vascular epidemic.25,26 The presence of a high amount of
cholesterol in the diet has been demonstrated to elevate
total cholesterol and may increase the risk of cardiovas-
cular complications. Agents that can lower serum choles-
terol and scavenge or inhibit free radical formation have
gained wide therapeutic value. Great efforts have been
made to reduce the risk of CVD through the regulation of
cholesterol, and the therapeutic benefits of plants have
been the focus of many extensive dietary study.27,28
In the present study, we investigated the lipid-lowering
effect of C dactylon in rats fed a high-cholesterol diet
for 45 days. Notably, the rats intubated with the dietary
cholesterol showed a significant increase in the circulating
total cholesterol, LDL-cholesterol, VLDL cholesterol, and
also in the ratio of TC:HDL-c. These results are consistent
with earlier reports29,30 that established a correlation
between dietary lipids and serum lipid profile. Supple-
mentation of cholesterol in the diet rapidly results in
a marked increase in the production of cholesteryl ester-
rich VLDL by the liver and intestine31 and a reduced rate
of cholesterol removal by the hepatic LDL receptors.31
Consequently serum levels of LDL-c and VLDL-c are
increased. A significant increased in the ratio of TC:HDL-c
indicates an increased risk of CVDs.32
Simultaneous administration of C dactylon extract
caused a significant decrease in serum TC, LDL-c, and
VLDL-c, suggesting a beneficial modulatory influence on
cholesterol metabolism and turnover. The reduction in the
ratio of TC:HDL-c observed in the extract-treated rats
might be a consequence of a higher proportion of HDL-c,
which could be due to increased reverse cholesterol
transport from peripheral organs to the liver.33,34 Elevated
serum TG is considered an independent risk factor for
CVD.35 TG accumulation caused by dietary cholesterol may
contribute to the reduction of fatty acid beta-oxidation and
the preference of cholesterol ester to afflux to LDL during
the onset of biosynthesis and secretion of LDL.36,37 A
significant decline in the serum TG concentration observed
in extract-treated rats supports the cardiovascular protec-
tive influence. The mechanism by which C dactylon extract
lowered the serum TG concentration could be either by
decreasing VLDL synthesis, by channeling VLDL through
pathways other than to LDL, or an increase in lipoprotein
lipase activity. Phytochemical studies of this plant have
shown the presence of glycosides, flavonoids, alkaloids,
tannins, and saponins. The observed hypolipidemic effect
might be due to individual or synergistic action of these
components, possibly by controlling the hydrolysis of
certain lipoproteins and their selective uptake and
metabolism by different tissues. Alternatively, the compo-
nents might exert a modulatory influence on lipogenic
enzymes or by inhibition of cholesterol absorption.38e40Based on the present results we suggest that C dactylon
might elicit beneficial effects by lowering the plasma lipid
levels of the treated rats. This is a preliminary study; it is
among the earliest reported work regarding the anti-
hyperlipidemic activity of C dactylon. C dactylon has been
traditionally used to cure a variety of illnesses. The results
of the present study add other beneficial effects. Further
studies are required to gain more insight in to the mecha-
nism of hypolipidemic action.
Conclusion
Evidence from this study confirms the lipid-lowering effects
of C dactylon in rats fed a high-cholesterol diet. The active
components in the C dactylonmight cause a decrease in the
serum lipid profile. Further studies are warranted to
determine the exact mechanism leading to the observed
effect; the component responsible may be a candidate for
use as a prophylactic agent against hypercholesterolemia.
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